There are few organizations that operate without constraints – especially when it comes to finances and/or professional staff. Because of limits on the amount of funds available to conduct experiments, buy new equipment and/or build larger facilities, as well as constraints on the number or type of talent an organization can hire and support, difficult decisions must be made regarding how to spend the available resources in the most effective manner.

For larger companies with pipelines filled with a broad range of products, regular assessments of the progress and likely payback of each product in development is critical to ensuring resources are allocated appropriately. These companies also need to plan for life cycle management of marketed products and ensure there are follow-on products in the pipeline to fill in gaps that are inevitably created as products mature and ultimately face generic competition.

For smaller companies with limited pipelines, the importance of selecting the best one or two compounds or products on which to place the organization's bets is critical to the survival of the company.
  • Portfolio prioritization
  • Screening indications to identify the best application(s) for a product in development
  • Screening drugs for drug delivery technologies
  • Life cycle planning

View our Portfolio Planning case examples.